| Year |
Milestone |
| 1873 |
Dr. Heinrich Byk sets up the company “Dr. Heinrich Byk AG” in Berlin |
| 1907 |
Euphyllin, a drug that even today still plays an important role in the therapy of respiratory disorders, is patented and gains an international reputation. |
| 1915 |
At the age of 70, Heinrich Byk hands over the business to Paul Gulden. |
| 1941 |
Dr. Günther Quandt, a businessman, acquires a majority of the company’s shares. |
| 1946 |
Byk Gulden Lomberg started again in Konstanz. |
| 1957 |
Byk Gulden Lomberg introduces Riopan, still used today to treat stomach problems. |
| 1976 |
Ebrantil – an effective product to reduce high blood pressure, is patented. |
| 1979 |
Byk Gulden opens a new facility to produce active substances in Singen. Singen is now also home to the company’s logistics center. |
| 1994 |
Pantoprazole is launched. It is used in about 100 countries to treat acid-related stomach and duodenal disorders and inflammation of the esophagus. |
| 2002 |
The company’s name is changed to ALTANA Pharma AG. As part of a move towards greater internationalisation, Byk Gulden Lomberg takes on the name of the parent company and corporate holding company,
ALTANA AG. |
| 2002 |
The ALTANA Research Institute (ARI) opens in Waltham near Boston. |
| 2003 |
Two new research buildings open at the company’s headquarters in Konstanz. |
| 2004 |
First approvals of Alvesco ®.
The ground-breaking ceremony for an ALTANA Pharma research institute is held in Mumbai, India.
Production of active ingredients starts in the new facility in block W32 in Singen, Germany. |
| 2005 |
First Launches of Alvesco ®. |
| 2006 |
New Institute of Preclinical Drug Safety in Barsbüttel, Germany, opens.
New production facility in Cork, Ireland, opens |
| 2007 |
ALTANA Pharma Pty Ltd becomes Nycomed Pty Ltd |